As shown in Figure 4A, treatment of Lewis lung carcinoma (LLC1) or T-cell lymphoma (EL4) cells generated significant levels of PAF-R agonistic activity. The gene discussed is PTAFR; the disease is T-cell non-Hodgkin lymphoma.